126 related articles for article (PubMed ID: 38030138)
1. Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure.
Erhardsson M; Faxén UL; Venkateshvaran A; Hage C; Pironti G; Thorvaldsen T; Webb DL; Hellström PM; Andersson DC; Ståhlberg M; Lund LH
ESC Heart Fail; 2024 Feb; 11(1):601-605. PubMed ID: 38030138
[TBL] [Abstract][Full Text] [Related]
2. Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization.
Lund LH; Hage C; Pironti G; Thorvaldsen T; Ljung-Faxén U; Zabarovskaja S; Shahgaldi K; Webb DL; Hellström PM; Andersson DC; Ståhlberg M
Eur Heart J; 2023 Jun; 44(22):2009-2025. PubMed ID: 36916707
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional right ventriculo-arterial coupling as an independent determinant of severe heart failure symptoms in patients with dilated cardiomyopathy.
Vîjîiac A; Onciul S; Deaconu S; Vătășescu R; Guzu C; Verinceanu V; Scărlătescu A; Zamfir D; Petre I; Scafa-Udriște A; Dorobanţu M
Echocardiography; 2022 Feb; 39(2):194-203. PubMed ID: 34997602
[TBL] [Abstract][Full Text] [Related]
4. Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.
Schmeißer A; Rauwolf T; Groscheck T; Fischbach K; Kropf S; Luani B; Tanev I; Hansen M; Meißler S; Schäfer K; Steendijk P; Braun-Dullaeus RC
ESC Heart Fail; 2021 Aug; 8(4):2968-2981. PubMed ID: 33934536
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
6. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension.
Rex S; Missant C; Claus P; Buhre W; Wouters PF
Crit Care; 2008; 12(5):R113. PubMed ID: 18783596
[TBL] [Abstract][Full Text] [Related]
9. Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.
Cooper TJ; Cleland JGF; Guazzi M; Pellicori P; Ben Gal T; Amir O; Al-Mohammad A; Clark AL; McConnachie A; Steine K; Dickstein K
Eur J Heart Fail; 2022 Jul; 24(7):1239-1248. PubMed ID: 35596935
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial.
Bundgaard H; Axelsson Raja A; Iversen K; Valeur N; Tønder N; Schou M; Christensen AH; Bruun NE; Søholm H; Ghanizada M; Fry NAS; Hamilton EJ; Boesgaard S; Møller MB; Wolsk E; Rossing K; Køber L; Rasmussen HH; Vissing CR
Circ Heart Fail; 2022 Jul; 15(7):e009120. PubMed ID: 35758031
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive right ventriculo-arterial coupling as a rehospitalization predictor in dilated cardiomyopathy: A comparison of five different methods.
Vîjîiac A; Bătăilă V; Onciul S; Verinceanu V; Guzu C; Deaconu S; Petre I; Scărlătescu A; Zamfir D; Dorobanţu M
Kardiol Pol; 2022; 80(2):182-190. PubMed ID: 34939658
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous ferric carboxymaltose on right ventricular function - insights from the IRON-CRT trial.
Martens P; Dupont M; Dauw J; Nijst P; Bertrand PB; Tang WHW; Mullens W
Eur J Heart Fail; 2022 Jun; 24(6):1106-1113. PubMed ID: 35303390
[TBL] [Abstract][Full Text] [Related]
13. Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
Dachs TM; Duca F; Rettl R; Binder-Rodriguez C; Dalos D; Ligios LC; Kammerlander A; Grünig E; Pretsch I; Steringer-Mascherbauer R; Ablasser K; Wargenau M; Mascherbauer J; Lang IM; Hengstenberg C; Badr-Eslam R; Kastner J; Bonderman D
Eur Heart J; 2022 Sep; 43(36):3402-3413. PubMed ID: 35909264
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vascular response to exercise in symptomatic heart failure with reduced ejection fraction and pulmonary hypertension.
Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Grieten L; Dens J; Verhaert D; Janssens S; Tang WH; Mullens W
Eur J Heart Fail; 2015 Mar; 17(3):320-8. PubMed ID: 25639263
[TBL] [Abstract][Full Text] [Related]
15. Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
Lewis GD; Voors AA; Cohen-Solal A; Metra M; Whellan DJ; Ezekowitz JA; Böhm M; Teerlink JR; Docherty KF; Lopes RD; Divanji PH; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A; Felker GM
JAMA; 2022 Jul; 328(3):259-269. PubMed ID: 35852527
[TBL] [Abstract][Full Text] [Related]
16. [Experts consensus on the management of the right heart function in critically ill patients].
Wang XT; Liu DW; Zhang HM; Long Y; Guan XD; Qiu HB; Yu KJ; Yan J; Zhao H; Tang YQ; Ding X; Ma XC; Du W; Kang Y; Tang B; Ai YH; He HW; Chen DC; Chen H; Chai WZ; Zhou X; Cui N; Wang H; Rui X; Hu ZJ; Li JG; Xu Y; Yang Y; Ouyan B; Lin HY; Li YM; Wan XY; Yang RL; Qin YZ; Chao YG; Xie ZY; Sun RH; He ZY; Wang DF; Huang QQ; Jiang DP; Cao XY; Yu RG; Wang X; Chen XK; Wu JF; Zhang LN; Yin MG; Liu LX; Li SW; Chen ZJ; Luo Z;
Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):962-973. PubMed ID: 29202543
[TBL] [Abstract][Full Text] [Related]
17. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
Franciosa JA; Jordan RA; Wilen MM; Leddy CL
Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
[TBL] [Abstract][Full Text] [Related]
18. Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial.
Omar M; Jensen J; Ali M; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Tuxen CD; Möller S; Gustafsson F; Køber L; Schou M; Møller JE
JAMA Cardiol; 2021 Jul; 6(7):836-840. PubMed ID: 33404637
[TBL] [Abstract][Full Text] [Related]
19. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
[TBL] [Abstract][Full Text] [Related]
20. Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia.
Cohen RI; Shapir Y; Chen L; Scharf SM
Crit Care Med; 1998 Apr; 26(4):738-47. PubMed ID: 9559613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
